Results 161 to 170 of about 43,230 (204)

Intrapleural streptokinase for the treatment of complicated parapneumonic effusion and empyema in 2 newborns

Journal of Pediatric Surgery, 2012
The management of complicated parapneumonic effusions by conventional first-line treatment with closed intercostal tube drainage and antibiotic therapy may fail because of thick viscous fluid and multiple pleural space loculations.
Şerife Suna Oguz, Ismail Kursad Gökçe
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Parapneumonic Effusions and Empyema

Seminars in Respiratory and Critical Care Medicine, 2001
Parapneumonic effusions occur in up to 60% of patients hospitalized with community acquired pneumonia. Fortunately, the majority of these effusions follow an uncomplicated course responding to antibiotic therapy alone. An important subgroup of patients, however, follow a complicated course progressing to an empyema unless infected pleural fluid is ...
J E, Heffner, J, Klein
openaire   +4 more sources

Parapneumonic effusions

The American Journal of Medicine, 1980
In this study the incidence and course of pleural effusions (parapneumonic effusions) in patients with acute bacterial pneumonia were prospectively evaluated. Bilateral decubitus chest x-ray films were obtained within 72 hours of admission in 203 patients with an acute febrile illness, purulent sputum and an infiltrate evident on the chest film. Ninety
R W, Light, W M, Girard, S G, Jenkinson, R B, George   +3 more
openaire   +2 more sources

MANAGEMENT OF PARAPNEUMONIC EFFUSIONS

Clinics in Chest Medicine, 1998
When a patient with a parapneumonic pleural effusion is first evaluated, a therapeutic thoracentesis should be performed if more than a minimal amount of pleural fluid is present. Fluid obtained at the therapeutic thoracentesis should be gram-stained and cultured and analyzed for glucose, pH, LDH, white blood cells, and differential cell count.
R W, Light, R M, Rodriguez
openaire   +2 more sources

Management of complicated parapneumonic effusions

Current Opinion in Pulmonary Medicine, 2022
Purpose of review Approximately 36–57% of cases of pneumonia are associated with a parapneumonic effusion (PPE). It begins as sterile effusion, which can quickly evolve to a fibrinopurulent stage with evidence of infection called complicated parapneumonic effusions (CPPE). Marked fibrinous organization then follows.
Sahar, Sultan, Ena, Gupta, Sadia, Benzaquen   +2 more
openaire   +2 more sources

Dexamethasone for Parapneumonic Pleural Effusion: A Randomized, Double-Blind, Clinical Trial

Journal of Pediatrics, 2017
OBJECTIVE: To assess whether dexamethasone (DXM) decreases the time to recovery in patients with parapneumonic pleural effusion. STUDY DESIGN: This was a multicenter, randomized, double blind, parallel-group, placebo-controlled clinical trial of 60 ...
Luis M Prieto, Enrique Otheo, Pablo Rojo   +2 more
exaly   +2 more sources

Parapneumonic Effusions and Empyema

Clinics in Chest Medicine, 1985
Abstract Parapneumonic effusions occur in 20 to 40% of patients who are hospitalized with pneumonia. The mortality rate in patients with a parapneumonic effusion is higher than that in patients with pneumonia without a parapneumonic effusion.
openaire   +3 more sources

Bacteriology of complicated parapneumonic effusions

Current Opinion in Pulmonary Medicine, 2007
The bacteriology of complicated parapneumonic effusions has changed in recent decades, but the causative organisms often remain obscure in up to 40% of cases. Recently, new molecular methods have become available which might help clinical management and improve our understanding of this condition.
Sarah, Foster, Nick, Maskell
openaire   +2 more sources

Diagnosis and Management of Parapneumonic Effusions

Seminars in Respiratory and Critical Care Medicine, 2008
Parapneumonic effusions affect many patients and are associated with considerable morbidity and mortality. It is necessary to differentiate complicated effusions requiring intervention from uncomplicated effusions. Differentiation is achieved using clinical, pleural fluid, and imaging parameters.
Christopher, Hampson, Julio A, Lemos, Jeffrey S, Klein   +2 more
openaire   +2 more sources

Percutaneous management of parapneumonic effusions

European Journal of Radiology, 2005
Parapneumonic effusions continue to be a significant source of morbidity and mortality. Treatment at earlier stages before fibrous peel and loculations occur has a much better prognosis. Using image guidance, addition of intracavitary fibrinolytic instillation, close follow-up with drainage of residual or new collections are some of the other factors ...
Akhan, O, Omen, MN, Ozkan, OS
openaire   +3 more sources